Preoperative assessment of malignant potential of gastrointestinal stromal tumor by dual-time-point 18F-fluorodeoxyglucose positron emission tomography imaging: Usefulness of standardized uptake value and retention index

被引:3
|
作者
Kwon, Yeongkeun [1 ]
Park, Eunkyung [5 ]
Pahk, Kisoo [2 ]
Kim, Sungeun [2 ]
Kim, Min Ju [3 ]
Graf, Daniel [6 ]
Park, Sungsoo [4 ]
机构
[1] Korea Univ, Coll Med, Dept Family Med, Seoul, South Korea
[2] Korea Univ, Coll Med, Dept Nuclr Med, Seoul, South Korea
[3] Korea Univ, Coll Med, Dept Radiol, Seoul, South Korea
[4] Korea Univ, Coll Med, Dept Surg, Div Upper Gastrointestinal Surg, Seoul, South Korea
[5] Yale Univ, Dept Diagnost Radiol, PET Ctr, New Haven, CT 06510 USA
[6] SUNY Buffalo, Dept Nucl Med, Buffalo, NY USA
关键词
Gastrointestinal stromal tumor; positron emission tomography; retention index; standardized uptake value; SOFT-TISSUE SARCOMA; FDG-PET; F-18-FDG PET; GIST; DIFFERENTIATION; PREDICTION; SUNITINIB; DIAGNOSIS; SURVIVAL; LESIONS;
D O I
10.4103/jcrt.JCRT_1093_16
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: To evaluate the usefulness of preoperative imaging with F-18 fluorodeoxyglucose positron emission tomography (FDG-PET) for noninvasive risk assessment of gastrointestinal stromal tumor (GIST). Materials and Methods: A retrospective review including 32 patients with pathologically proven GIST. Preoperative FDG-PET scan results including maximum standardized uptake values (SUVs) of the GISTs at 1 h postinjection (SUV1) were available for all tumors and SUVs at 2 h postinjection (SUV2) were available for 22 tumors. When both SUV1 and SUV2 were available, a retention index (RI, %) was calculated, and the correlation of these PET parameters with the histopathologic results was analyzed. Results: SUV1 was significantly higher in tumors in the high-risk group (6.0 +/- 2.7) compared to those in the low risk (3.0 +/- 1.6) or very low-risk (2.7 +/- 1.2) groups (P = 0.009 and 0.011, respectively). At a cutoff of 5.2, the SUV1 demonstrated sensitivity of 80% and a specificity of 89% for predicting high-risk GISTs. Tumor size was significantly correlated with SUV1 (r = 0.68, P < 0.001) and SUV2 (r = 0.66, P = 0.001), and SUV1, SUV2, and RI were significantly higher in tumors with mitotic index > 5/50 high-power field than in those with lower mitotic index. RI was significantly higher in tumors with C-kit mutation than in those with no C-kit mutation. Conclusion: SUV1 measured during preoperative FDG-PET imaging correlated well with malignant potential of GISTs, especially for high-risk versus Low-/very-low-risk tumors. RI values correlated well with mitotic counts and C-kit mutation, suggesting that this mutation may have some influence on tumor metabolism.
引用
收藏
页码:142 / 147
页数:6
相关论文
共 50 条
  • [1] Prognostic value of dual-time-point 18F-fluorodeoxyglucose positron emission tomography in patients with pulmonary sarcoidosis
    Umeda, Yukihiro
    Demura, Yoshiki
    Morikawa, Miwa
    Ameshima, Shingo
    Tsuchida, Tatsuro
    Fujibayashi, Yasuhisa
    Okazawa, Hidehiko
    Ishizaki, Takeshi
    RESPIROLOGY, 2011, 16 (04) : 713 - 720
  • [2] 18F-Fluorodeoxyglucose Positron Emission Tomography: Useful Technique for Predicting Malignant Potential of Gastrointestinal Stromal Tumors
    Yoichi Kamiyama
    Ryuusuke Aihara
    Toshihiro Nakabayashi
    Erito Mochiki
    Takayuki Asao
    Hiroyuki Kuwano
    Nobuo Oriuchi
    Keigo Endo
    World Journal of Surgery, 2005, 29 : 1429 - 1435
  • [3] 18F-Fluorodeoxyglucose positron emission tomography:: Useful technique for predicting malignant potential of gastrointestinal stromal tumors
    Kamiyama, Y
    Aihara, R
    Nakabayashi, T
    Mochiki, E
    Asao, T
    Kuwano, H
    Oriuchi, N
    Endo, K
    WORLD JOURNAL OF SURGERY, 2005, 29 (11) : 1429 - 1435
  • [4] Prognostic value of the standardized uptake value maximum change calculated by dual-time-point 18F-fluorodeoxyglucose positron emission tomography imaging in patients with advanced non-small-cell lung cancer
    Jin, Feng
    Zhu, Hui
    Fu, Zheng
    Kong, Li
    Yu, Jinming
    ONCOTARGETS AND THERAPY, 2016, 9 : 2993 - 2999
  • [5] The maximum standardized uptake value increment calculated by dual-time-point 18F-fluorodeoxyglucose positron emission tomography predicts survival in patients with oral tongue squamous cell carcinoma
    Yonezawa, Natsuki
    Minamikawa, Tsutomu
    Kitajima, Kazuhiro
    Takahashi, Yusuke
    Sasaki, Ryohei
    Nibu, Ken-ichi
    Komori, Takahide
    NAGOYA JOURNAL OF MEDICAL SCIENCE, 2017, 79 (02): : 189 - 198
  • [6] Clinical Applications of 18F-Fluorodeoxyglucose Positron Emission Tomography in Gastrointestinal Stromal Tumor of the Esophagus
    Sakai, Makoto
    Kato, Hiroyuki
    Saito, Kana
    Tanaka, Naritaka
    Inose, Takanori
    Kimura, Hitoshi
    Miyazaki, Tatsuya
    Kuwano, Hiroyuki
    INTERNATIONAL SURGERY, 2008, 93 (04) : 209 - 213
  • [7] Genomic Signature of the Standardized Uptake Value in 18F-Fluorodeoxyglucose Positron Emission Tomography in Breast Cancer
    Kim, Seon-Kyu
    Ahn, Sung Gwe
    Mun, Jeong-Yeon
    Jeong, Mi-So
    Bae, Soong June
    Lee, Ju-Seog
    Jeong, Joon
    Leem, Sun-Hee
    Chu, In-Sun
    CANCERS, 2020, 12 (02)
  • [8] Standardized uptake values of normal organs on 18F-fluorodeoxyglucose positron emission tomography and computed tomography imaging
    Zincirkeser, S.
    Sahin, E.
    Halac, M.
    Sager, S.
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2007, 35 (02) : 231 - 236
  • [9] Prognostic value of metabolic tumor burden calculated using dual-time-point 18F-fluorodeoxyglucose positron emission tomography/CT in patients with oropharyngeal or hypopharyngeal cancer
    Kuwabara, Hirofumi
    Toriihara, Akira
    Yuasa-Nakagawa, Keiko
    Toda, Kazuma
    Tateishi, Ukihide
    Yoshimura, Ryoichi
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2019, 41 (01): : 103 - 109
  • [10] Standardized uptake value of 18F-fluorodeoxyglucose positron emission tomography for prediction of tumor recurrence in breast cancer beyond tumor burden
    Ahn, Sung Gwe
    Park, Jong Tae
    Lee, Hak Min
    Lee, Hak Woo
    Jeon, Tae Joo
    Han, Kyunghwa
    Lee, Seung Ah
    Dong, Seung Myung
    Ryu, Young Hoon
    Son, Eun Ju
    Jeong, Joon
    BREAST CANCER RESEARCH, 2014, 16 (06):